Cannabis
Nass Valley Announces Engagement with Stockhouse
Vancouver, British Columbia–(Newsfile Corp. – September 20, 2021) – Nass Valley Gateway (CSE: NVG) is excited to announce that the company has engaged Stockhouse Publishing Ltd. (“Stockhouse”) to assist with investor and brand awareness as well as market outreach as Nass Valley continues to achieve important milestones and grow its investor base.
“Stockhouse is one of the most well-respected companies in the investor awareness space, especially for companies that trade publicly on the Canadian Stock Exchange,” said Michael Semler, CEO of Nass Valley. “We are confident that through this relationship, Nass Valley will be exposed to a large, targeted investor community.”
Stockhouse is providing Nass Valley with their full suite of marketing tools that include 30 different services around brand awareness. The contract executed on the 8th of September is valued at $100,000. This relationship will run for twelve months from September 2021 through August 2022 and provide an option to renew.
All content produced will be published throughout the Stockhouse network as well as through Nass Valley’s network.
ABOUT STOCKHOUSE Ltd.
Stockhouse Publishing Ltd. is a leading financial media company that serves public companies, financial institutions, media publishers, and brand advertisers. Stockhouse members have access to a wide range of world-class products and tools including portfolio managers, subscription-based expert newsletters, Stockhouse Bullboards, blogs, and social networking tools to help navigate their investment options. With over nine million unique visitors annually, Stockhouse is Canada’s #1 financial portal and one of North America’s largest small-cap investor communities.
ABOUT NASS VALLEY GATEWAY LTD.
Nass Valley Gateway LTD (NVG) is a publicly traded company listed on the CSE, focused on the sales and distribution of organic, non-GMO, CBD products for pet and human consumption. Nass Valley CBD products are sold under the “Nass Valley Gardens” brand, an affiliate, via retail, wholesale, direct sales, and digital sales channels.
We seek Safe Harbor.
Neither the CSE nor its Regulation Services Provider has reviewed or accepts responsibility for the adequacy or accuracy of the contents of this news release.
Company: Nass Valley Gateway Ltd.
422 Richards Street, Suite 170
V6B 2Z4 Vancouver, Canada
E-mail: [email protected]
Corporate Website: www.nassvalleygateway.com
Product Website: www.nassvalleyproducts.com
For more information:
Michael Semler, CEO
Nass Valley Gateway
[email protected]
(800) 458-0154
Mike Magolnick, PR
The Red Flag Image Company
[email protected]
(214) 799-0730
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/97021.
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Cannabis2 weeks ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
transfer2 weeks ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis1 week ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®2 weeks ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan4 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf5 days ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis4 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care